IDEXX Laboratories, Inc.
USD560.73
+9.91 (+1.80%)
CEO
Jonathan J. Mazelsky
IPO Date
1991-06-21
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$548.92
Prev. Close
$550.82
Day Low
$547.57
Day High
$561.74
52W Low
$506.91
52W High
$769.98
Market Cap
$44.23B
Volume
0.88M
| 38.4 |
| 31 Dec 2023 | FY | 59.8% | 23.1% | 56.9% | 25.9% | 0.72 | 1.57 | 54.6 |
| 31 Dec 2022 | FY | 59.5% | 20.2% | 111.6% | 24.7% | 2.22 | 0.89 | 50.2 |
| 31 Dec 2021 | FY | 58.8% | 23.2% | 107.9% | 30.6% | 1.34 | 1.25 | 75.3 |
| 31 Dec 2020 | FY | 58.0% | 21.5% | 92.0% | 25.4% | 1.44 | 1.82 | 73.3 |
| 31 Dec 2019 | FY | 56.7% | 17.8% | 241.0% | 23.3% | 5.57 | 0.94 | 52.6 |
| 31 Dec 2018 | FY | 56.1% | 17.0% | -3963.3% | 24.5% | -105.15 | 0.85 | 42.9 |
| 31 Dec 2017 | FY | 55.7% | 13.4% | -486.3% | 15.4% | -23.31 | 0.97 | 52.2 |
| 31 Dec 2016 | FY | 54.9% | 12.5% | -204.9% | 14.5% | -11.11 | 0.90 | 47.4 |
| 46.6 |
| 30 Jun 2025 | Q2 | 62.6% | 26.5% | 20.2% | 8.8% | 0.85 | 1.11 | 36.7 |
| 31 Mar 2025 | Q1 | 62.4% | 24.3% | 16.8% | 7.6% | 0.73 | 1.16 | 35.2 |
| 31 Dec 2024 | Q4 | 59.8% | 22.7% | 13.5% | 6.6% | 0.62 | 1.31 | 39.1 |
| 30 Sept 2024 | Q3 | 61.1% | 23.9% | 14.4% | 6.9% | 0.62 | 1.42 | 44.6 |
| 30 Jun 2024 | Q2 | 61.9% | 20.3% | 12.9% | 6.0% | 0.68 | 1.32 | 48.4 |
| 31 Mar 2024 | Q1 | 61.5% | 24.4% | 15.0% | 7.0% | 0.68 | 1.57 | 46.9 |
| 31 Dec 2023 | Q4 | 58.4% | 21.6% | 13.1% | 6.0% | 0.64 | 1.57 | 59.3 |
| 30 Sept 2023 | Q3 | 59.9% | 23.2% | 16.4% | 6.9% | 0.79 | 1.43 | 42.8 |